Boehringer Ingelheim International is a pharmaceutical company engaged in human and animal health, and biopharmaceutical contract manufacturing. It focuses on drug discovery and development and offering treatment of heart, metabolic, lung, skin, and retinal diseases, as well as cancer, and mental disorders. The company also develops solutions and provide services to protect animals from disease and pain by providing vaccines, parasiticides, and therapeutics, complemented by diagnostics and monitoring platforms.